News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
Tividenofusp alfa treatment showed reduction and normalization in key disease biomarkers, stabilization or improvement in clinical endpoints including adaptive behavior, cognition and hearing, and ...
Spruce bark is rich in phenolic compounds that protect trees from pathogenic fungi. A research team at the Max Planck ...
Fluoride remains the cornerstone of preventive dentistry, and researchers have analyzed the many delivery methods of fluoride ...
Stacker on MSN
Top science stories of 2025
Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...
The global transition to a hydrogen-based clean energy economy faces a critical bottleneck: current proton exchange membrane ...
The publication unveiled its annual selection of the most significant scientific and technological breakthroughs from the ...
The Chosun Ilbo on MSN
KIST, Hanyang University develop direct fatty liver fat treatment
A South Korean research team has developed a new treatment that directly removes fat accumulated in liver cells. The ...
The number of patients with metabolic dysfunction-associated fatty liver disease is rapidly increasing due to the spread of ...
Omeros Corporation (NASDAQ: OMER) today announced a revised date for its conference call to discuss the recent FDA approval ...
A significant body of research has repeatedly sounded the alarm, uncovering “alarmingly high levels of mercury” in numerous ...
WIRED spoke with DeepMind’s Pushmeet Kohli about the recent past—and promising future—of the Nobel Prize-winning research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results